Back to search

Article

Ambulatory BP and Weight Reduction as Predictors of GLP-1RA CV Benefit

2025-06-14

Abstract excerpt

<h4>Background</h4> GLP-1 receptor agonists (GLP-1RA) and dual GLP-1/GIP agonists reduce cardiovascular events in patients with type 2 diabetes and obesity. The extent to which these benefits are mediated by blood pressure (BP) reduction versus weight loss, especially in hypertensive patients, remains unclear. <h4>Methods</h4> We conducted a systematic review and meta-analysis of randomized controlled trials publi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ce147a5-721d-52a6-8fd4-6a1e86f77209
DOI
10.1101/2025.06.12.25329536
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ambulatory BP and Weight Reduction as Predictors of GLP-1RA CV BenefitDOI 10.1101/2025.06.12.25329536
Select a neighboring publication to make it the new centre.